Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Eros Receives NYSE Extension for Annual Report Filing
Eros Receives NYSE Extension for Annual Report Filing


Eros Media World Plc (NYSE: ESGC) (“Eros”, the “Company”) today announced that the New York Stock Exchange (the “NYSE”) has granted the Company an extension through August 1, 2022, subject to

DGAP-Adhoc: Q1 2022 results for Petro Welt Technologies AG: The Group closed Q1 2022 with a positive EBIT of EUR 1.1 million
DGAP-Adhoc: Q1 2022 results for Petro Welt Technologies AG: The Group closed Q1 2022 with a positive EBIT of EUR 1.1 million
DGAP-Adhoc: Q1 2022 results for Petro Welt Technologies AG: The Group closed Q1 2022 with a positive EBIT of EUR 1.1 million
PhosAgro PJSC: PhosAgro Board of Directors Elects New Management Board
PhosAgro PJSC: PhosAgro Board of Directors Elects New Management Board
PhosAgro PJSC: PhosAgro Board of Directors Elects New Management Board
Immersion Files Complaint Against Meta Platforms / Facebook With U.S. District Court for the Western District of Texas
Immersion Files Complaint Against Meta Platforms / Facebook With U.S. District Court for the Western District of Texas


Immersion Corporation (NASDAQ: IMMR), the leading developer and provider of technologies for haptics, today announced that it has filed a complaint against Meta Platforms, Inc. (formerly known as

Agilent Announces Collaboration with APC on Real-Time Process Monitoring
Agilent Announces Collaboration with APC on Real-Time Process Monitoring


Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique

Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA
Power Integrations to Participate in Upcoming Investor Conferences
Power Integrations to Participate in Upcoming Investor Conferences


Power Integrations (Nasdaq: POWI) today announced webcasts of appearances by company executives at the following investor conferences:




  • Cowen Technology, Media & Telecom Conference – June 2

Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Ozon Announces Its First Quarter 2022 Unaudited Financial Results
Ozon Announces Its First Quarter 2022 Unaudited Financial Results


Ozon Holdings PLC (NASDAQ and MOEX: “OZON”, thereafter referred to as “we”, “us”, “our”, “Ozon” or the “Company”), an operator of the leading Russian e-commerce platform, announces its unaudited

DGAP-News: Allterco JSCo reports unaudited consolidated Q1 2022 results on 30 May 2022 – Invitation to earnings webcast/call on 1 June 2022
DGAP-News: Allterco JSCo reports unaudited consolidated Q1 2022 results on 30 May 2022 – Invitation to earnings webcast/call on 1 June 2022
DGAP-News: Allterco JSCo reports unaudited consolidated Q1 2022 results on 30 May 2022 – Invitation to earnings webcast/call on 1 June 2022
Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022
Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that an abstract reporting

Magnit announces the results of the Board meeting
Magnit announces the results of the Board meeting
Magnit announces the results of the Board meeting
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: Photon Energy Group Successfully Taps its 6.50% Green Bond to 65 Million Euros
DGAP-News: Photon Energy Group Successfully Taps its 6.50% Green Bond to 65 Million Euros
DGAP-News: Photon Energy Group Successfully Taps its 6.50% Green Bond to 65 Million Euros
Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting
Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the publication of two abstracts on neratinib to be presented at the 2022 American Society of Clinical Oncology

Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported initial

Douglas Emmett Declares Quarterly Cash Dividend
Douglas Emmett Declares Quarterly Cash Dividend


Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today that its Board of Directors has declared a quarterly cash dividend on each share of its common stock of

This Father’s Day, Advance Auto Parts and Pennzoil Team Up to Offer the Ultimate Trip with Dad
This Father’s Day, Advance Auto Parts and Pennzoil Team Up to Offer the Ultimate Trip with Dad


Advance Auto Parts (NYSE: AAP), a leading automotive aftermarket parts provider, has teamed up with Pennzoil® to offer motorsports race fans the chance to win a once-in-a-lifetime Father’s Day

Brown‑Forman Declares Cash Dividend
Brown‑Forman Declares Cash Dividend


Brown-Forman Corporation (NYSE: BFA) (NYSE: BFB) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.1885 per share on its Class A and Class B Common Stock

Gap Inc. Reports First Quarter Fiscal 2022 Results and Provides Updated Fiscal 2022 Outlook
Gap Inc. Reports First Quarter Fiscal 2022 Results and Provides Updated Fiscal 2022 Outlook


Gap Inc. (NYSE: GPS), a portfolio of purpose-led, billion-dollar lifestyle brands including Old Navy, Gap, Banana Republic, and Athleta, and the largest specialty apparel company in the U.S., today